Company Filing History:
Years Active: 2007-2013
Title: The Innovations of David L. Bartlett
Introduction
David L. Bartlett is a notable inventor based in Pittsburgh, PA, who has made significant contributions to the field of biomedical research. With a focus on cancer treatment, he has developed innovative technologies that enhance the understanding and treatment of tumors. His work has led to the filing of two patents, showcasing his commitment to advancing medical science.
Latest Patents
David L. Bartlett's latest patents include groundbreaking inventions that utilize vaccinia virus expression vectors. The first patent, titled "Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell," describes a composition of matter comprising a vaccinia virus expression vector with a negative thymidine kinase phenotype and a negative vaccinia virus growth factor phenotype. The second patent, "Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector," also focuses on a similar composition, emphasizing the potential for targeted cancer therapies.
Career Highlights
David L. Bartlett is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to collaborate with leading researchers and contribute to significant advancements in health and medicine. His work is characterized by a dedication to improving therapeutic strategies for cancer patients.
Collaborations
Throughout his career, David has worked alongside esteemed colleagues, including J Andrea McCart and Bernard Moss. These collaborations have fostered an environment of innovation and have led to the development of impactful research in the field of oncology.
Conclusion
David L. Bartlett's contributions to the field of biomedical research through his patents and collaborations highlight his role as a key innovator in cancer treatment. His work continues to inspire advancements in medical science and offers hope for improved therapies for patients.